peginterferon lambda-1a

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2014-2016
02420142016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The study objective was to compare the efficacy and safety of peginterferon lambda-1a combined with ribavirin/daclatasvir (Lambda… (More)
Is this relevant?
2016
2016
BACKGROUND A randomized, double-blind, multinational, phase 3 study was conducted comparing the efficacy and safety of… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2016
2016
AIM This study explores the potential role of a novel interferon-containing regimen for treatment of patients with chronic… (More)
  • figure 1
  • table 1
  • table 3
  • figure 2
  • table 2
Is this relevant?
2016
2016
The phase 2b EMERGE study compared the efficacy/safety of peginterferon lambda-1a (Lambda) and peginterferon alfa-2a (Alfa), both… (More)
Is this relevant?
2016
2016
BACKGROUND AND PURPOSE Peginterferon Lambda was being developed as an alternative to alfa interferon for the treatment of chronic… (More)
  • table 1
  • table 2
  • table 2
Is this relevant?
2015
2015
This is the second of two manuscripts detailing the pharmacodynamic derivation of peginterferon lambda-1a (Lambda) dosing and… (More)
Is this relevant?
2014
2014
BACKGROUND & AIMS Peginterferon lambda-1a (Lambda) is a type-III interferon with similar antiviral activity to alfa interferons… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?